BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12957763)

  • 1. The predictive power of low-density lipoprotein cholesterol for coronary calcification.
    Allison MA; Wright M; Tiefenbrun J
    Int J Cardiol; 2003 Aug; 90(2-3):281-9. PubMed ID: 12957763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of HDL and LDL cholesterol for prevalent coronary calcification.
    Allison MA; Wright CM
    Int J Cardiol; 2004 May; 95(1):55-60. PubMed ID: 15159039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein and noncalcified coronary plaque composition in patients with newly diagnosed coronary artery disease on computed tomographic angiography.
    Cheng VY; Wolak A; Gutstein A; Gransar H; Wong ND; Dey D; Thomson LE; Hayes SW; Friedman JD; Slomka PJ; Berman DS
    Am J Cardiol; 2010 Mar; 105(6):761-6. PubMed ID: 20211316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.
    Hecht HS; Superko HR
    J Am Coll Cardiol; 2001 May; 37(6):1506-11. PubMed ID: 11345357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).
    Matsuzaki M; Hiramori K; Imaizumi T; Kitabatake A; Hishida H; Nomura M; Fujii T; Sakuma I; Fukami K; Honda T; Ogawa H; Yamagishi M
    J Am Coll Cardiol; 2002 Jul; 40(2):220-7. PubMed ID: 12106923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography.
    Hecht HS; Harman SM
    Am J Cardiol; 2003 Aug; 92(3):334-6. PubMed ID: 12888149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between epicardial adipose tissue volume measured using coronary computed tomography angiography and atherosclerotic plaque characteristics in patients with severe coronary artery stenosis.
    Dong DD; Wang K; Wang D; Zhang T; Tu YF; Shen BZ
    J Int Med Res; 2013 Oct; 41(5):1520-31. PubMed ID: 24045168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
    Callister TQ; Raggi P; Cooil B; Lippolis NJ; Russo DJ
    N Engl J Med; 1998 Dec; 339(27):1972-8. PubMed ID: 9869668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients.
    Yildiz A; Tepe S; Oflaz H; Yazici H; Pusuroglu H; Besler M; Ark E; Erzengin F
    Nephrol Dial Transplant; 2004 Apr; 19(4):885-91. PubMed ID: 15031345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent role of low-density lipoprotein cholesterol in subclinical coronary atherosclerosis in the absence of traditional cardiovascular risk factors.
    Won KB; Park GM; Yang YJ; Ann SH; Kim YG; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee SW; Kim YH; Kim SJ; Lee SG
    Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):866-872. PubMed ID: 31086966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of traditional cardiovascular risk factors with coronary plaque sub-types assessed by 64-slice computed tomography angiography in a large cohort of asymptomatic subjects.
    Rivera JJ; Nasir K; Cox PR; Choi EK; Yoon Y; Cho I; Chun EJ; Choi SI; Blumenthal RS; Chang HJ
    Atherosclerosis; 2009 Oct; 206(2):451-7. PubMed ID: 19524922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia.
    Miname MH; Ribeiro MS; Parga Filho J; Avila LF; Bortolotto LA; Martinez LR; Rochitte CE; Santos RD
    Atherosclerosis; 2010 Dec; 213(2):486-91. PubMed ID: 20980000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation.
    Achenbach S; Ropers D; Pohle K; Leber A; Thilo C; Knez A; Menendez T; Maeffert R; Kusus M; Regenfus M; Bickel A; Haberl R; Steinbeck G; Moshage W; Daniel WG
    Circulation; 2002 Aug; 106(9):1077-82. PubMed ID: 12196332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes.
    Mrgan M; Funck KL; Gaur S; Øvrehus KA; Dey D; Kusk MW; Nørgaard BL; Gram JB; Olsen MH; Gram J; Sand NPR
    Diab Vasc Dis Res; 2017 Nov; 14(6):468-476. PubMed ID: 28866908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of statin therapy on non-calcified coronary plaque assessed by 64-slice computed tomography.
    Kitagawa T; Yamamoto H; Horiguchi J; Ohashi N; Kunita E; Utsunomiya H; Kihara Y
    Int J Cardiol; 2011 Jul; 150(2):146-50. PubMed ID: 20542581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment.
    Hecht HS; Superko HR; Smith LK; McColgan BP
    Am J Cardiol; 2001 Feb; 87(4):406-12. PubMed ID: 11179523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
    Bayturan O; Kapadia S; Nicholls SJ; Tuzcu EM; Shao M; Uno K; Shreevatsa A; Lavoie AJ; Wolski K; Schoenhagen P; Nissen SE
    J Am Coll Cardiol; 2010 Jun; 55(24):2736-42. PubMed ID: 20538166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
    Superko HR; Hecht HS
    Am J Cardiol; 2001 Aug; 88(3):260-4. PubMed ID: 11472704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.